FAGR (Fagron NV) vs DAX Index Comparison

FAGR

DAX Index

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

FAGR

DAX Index

Difference

1Y 3Y 5Y 10Y 15Y 20Y

FAGR

DAX Index

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

DAX Index

FAGR

MCK

COR

0HF3

CAH

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Fagron NV
Glance View

Market Cap

1.2B EUR

Industry

Health Care

Fagron NV is a Belgian multinational company that has woven specialized pharmaceutical compounding into the fabric of modern healthcare. Founded in 1990, the company's mission has always been to advance personalized medicine by focusing on the compounding sector, which involves tailoring and mixing pharmaceutical ingredients to produce unique medications tailored to the specific needs of patients. By transforming individual healthcare demands into bespoke pharmaceutical solutions, Fagron serves the global medical community by manufacturing and distributing both active and inactive pharmaceutical ingredients, as well as offering various base products. This strategic positioning not only supports healthcare professionals and pharmacies in delivering specialized patient care but also fortifies the company's commitment to improving global health outcomes. The key to Fagron's business model lies in its adept integration of innovation alongside therapeutic and technological solutions, ensuring they maintain a strong presence within the compounding market. The company particularly thrives on its ability to address niches in the pharmaceutical industry, ones often overlooked by large pharma entities due to scale inefficiencies. Through its three principal segments—Pharmaceutical Compounding, Raw Materials, and Innovative Concepts—Fagron generates revenue by supplying pharmacies and medical institutions worldwide, from small community pharmacies to large hospital networks. Its broad portfolio of over 30,000 products caters to a spectrum of needs, fostering both patient-specific and bulk pharmaceutical solutions. By combining quality, safety, and regulatory compliance with a keen market understanding, Fagron NV continues to sustain its role as a crucial player in the personalized medicine arena.

View FAGR Analysis

FAGR Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US		Mckesson Corp NYSE:MCK	Select
US		Cencora Inc NYSE:COR	Select
US	A	Amerisourcebergen Corp LSE:0HF3	Select
US		Cardinal Health Inc NYSE:CAH	Select
US		Henry Schein Inc NASDAQ:HSIC	Select
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Select
CN		Sinopharm Group Co Ltd HKEX:1099	Select
CN		Huadong Medicine Co Ltd SZSE:000963	Select
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Select
IT		Amplifon SpA MIL:AMP	Select

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US	G	GE Vernova LLC NYSE:GEV	Add
NL	N	Nepi Rockcastle NV JSE:NRP	Add
US		Schlumberger NV NYSE:SLB	Add
US	B	Baker Hughes Co NASDAQ:BKR	Add
ID		Amman Mineral Internasional Tbk PT IDX:AMMN	Add
US	R	Reddit Inc NYSE:RDDT	Add
CH	G	Galderma Group AG SIX:GALD	Add
US		Halliburton Co NYSE:HAL	Add
LU		Tenaris SA MIL:TEN	Add
IN		Jio Financial Services Ltd NSE:JIOFIN	Add

	Franklin Covey Co NYSE:FC	34.55 USD -2.12%
	Mohawk Industries Inc NYSE:MHK	119.6 USD 1.12%
	Ardmore Shipping Corp NYSE:ASC	13.12 USD 4.46%
	ASGN Inc NYSE:ASGN	85.53 USD -1.6%
	Skyworks Solutions Inc NASDAQ:SWKS	92.135 USD -0.53%
	Weatherford International PLC NASDAQ:WFRD	72.13 USD -3.57%

FAGR

vs

DAX Index

Stocks Performance
FAGR vs DAX Index

Performance Gap
FAGR vs DAX Index

Performance By Year
FAGR vs DAX Index

Competitors Performance
Fagron NV vs Peers

Fagron NV
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	142.14 USD -0.09%
	Bank of America Corp NYSE:BAC	45.555 USD -1.42%
	Mastercard Inc NYSE:MA	512 USD -0.85%
	Salesforce Inc NYSE:CRM	319.255 USD -2.34%
	Abbvie Inc NYSE:ABBV	175.56 USD -1.65%
	Home Depot Inc NYSE:HD	387 USD -0.05%

	Arista Networks Inc NYSE:ANET	113.095 USD -2.09%
	Visa Inc NYSE:V	311.15 USD -0.46%
	Texas Pacific Land Corp NYSE:TPL	1 289.53 USD 1.07%
	KLA Corp NASDAQ:KLAC	674.125 USD -1.76%
	Manhattan Associates Inc NASDAQ:MANH	267 USD -2.01%
	Pinduoduo Inc NASDAQ:PDD	95.84 USD -4.47%

	Salesforce Inc NYSE:CRM	319.255 USD -2.34%
	ServiceNow Inc NYSE:NOW	1 027.05 USD -2.1%
	EOG Resources Inc NYSE:EOG	133.56 USD 3.97%
	Copart Inc NASDAQ:CPRT	55.98 USD -1.41%
	Applied Materials Inc NASDAQ:AMAT	170.2199 USD -3.83%
	Synopsys Inc NASDAQ:SNPS	493.77 USD -1.64%

	Johnson & Johnson NYSE:JNJ	142.14 USD -0.09%
	Berkshire Hathaway Inc NYSE:BRK.A	673 914.775 USD -0.59%
	Bank of America Corp NYSE:BAC	45.555 USD -1.42%
	Mastercard Inc NYSE:MA	512 USD -0.85%
	UnitedHealth Group Inc NYSE:UNH	534.175 USD 1.84%
	Exxon Mobil Corp NYSE:XOM	109.305 USD 2.22%

FAGR vs DAX Index

Stocks Performance FAGR vs DAX Index

Performance Gap FAGR vs DAX Index

Performance By Year FAGR vs DAX Index

Competitors Performance Fagron NV vs Peers

Fagron NV Glance View

Company

Help

Tools

Stocks

FAGR

vs

DAX Index

Stocks Performance
FAGR vs DAX Index

Performance Gap
FAGR vs DAX Index

Performance By Year
FAGR vs DAX Index

Competitors Performance
Fagron NV vs Peers

Fagron NV
Glance View